Appendix A
Agenda for Information-Gathering Meeting, Geneva, December 2005

COMMITTEE ON THE PREVENTION OF HIV INFECTION AMONG INJECTING DRUG USERS IN HIGH-RISK COUNTRIES

December 19–20, 2005

Geneva, Switzerland

December 19, 2005

9:00–9:15 a.m.

Welcome, Introductions, and Opening Statement

 

Hugh Tilson, M.D., Dr.PH.

Committee Chair

9:15–9:45 a.m.

Charge to the Committee

 

Peter Piot, M.D., Ph.D.

Executive Director, UNAIDS

Under Secretary-General of the United Nations

9:45–10:15 a.m.

Overview of Addiction

 

Michael Farrell, MRCPsych

Reader in Addiction Psychiatry, National Addiction Centre,

Institute of Psychiatry, King’s College, London



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 199
Appendix A Agenda for Information-Gathering Meeting, Geneva, December 2005 COMMITTEE ON THE PREVENTION OF HIV INFECTION AMONG INJECTING DRUG USERS IN HIGH-RISK COUNTRIES December 19–20, 2005 Geneva, Switzerland December 19, 2005 9:00–9:15 a.m. Welcome, Introductions, and Opening Statement   Hugh Tilson, M.D., Dr.PH. Committee Chair 9:15–9:45 a.m. Charge to the Committee   Peter Piot, M.D., Ph.D. Executive Director, UNAIDS Under Secretary-General of the United Nations 9:45–10:15 a.m. Overview of Addiction   Michael Farrell, MRCPsych Reader in Addiction Psychiatry, National Addiction Centre, Institute of Psychiatry, King’s College, London

OCR for page 199
10:15–11:00 a.m. Epidemiology of HIV/AIDS Among IDUs in High-Risk Countries and the Global Response   Peter Ghys, M.D. Acting Associate Director, Epidemic Monitoring and Prevention, Department of Policy, Evidence and Partnerships, UNAIDS   Catherine Anita Hankins, M.D., MSc, FRCPC Associate Director of Policy, Evidence and Partnerships Chief Scientific Adviser UNAIDS 11:00–11:15 a.m. Break 11:15–12:45 p.m. Evidence Regarding HIV Prevention for IDUs   Overview: Gerry V. Stimson Ph.D. Emeritus Professor, Imperial College London, and Executive Director, International Harm Reduction Association   Review of needle and syringe exchange programs: Dr. Alex Wodak FRACP, FChAM Director, Alcohol and Drug Service St. Vincent’s Hospital, Darlinghurst, Australia   Review of needle and syringe exchange programs: Kerstin Käll, M.D., Ph.D. Clinic for Dependency Disorders University Hospital, Linköping, Sweden   Review of drug treatment strategies: Michael Farrell, MRCPsych Reader in Addiction Psychiatry, National Addiction Centre, Institute of Psychiatry, King’s College, London 12:45–1:45 p.m. Lunch

OCR for page 199
1:45–3:15 p.m. Country Perspectives Panel: Asian and Pacific Countries   Zhang Fujie, M.D. Director, Division of Treatment and Care National Center for AIDS-STD Control and Prevention, Chinese Center for Disease of Control and Prevention   Adeeba Kamarulzaman, MBBS, FRACP Head, Infectious Diseases Unit Department of Medicine University of Malaya Medical Centre, Malaysia   Chris Beyrer, M.D., M.P.H. Associate Professor, Department of Epidemiology Director, Johns Hopkins Fogarty AIDS International Training and Research Program Director, Johns Hopkins Center for Public Health & Human Rights Johns Hopkins Bloomberg School of Public Health (discussing Thailand) 3:15–3:30 p.m. Break 3:30–5:45 p.m. Country Perspectives Panel: Former Soviet States, Central, and Eastern European Countries   Saulius Caplinskas, M.D., Ph.D. Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University   Monica Ciupagea M.D. Program Officer International Harm Reduction Development Program Open Society Institute, Budapest   Oleg Tchestnov, M.D. Deputy Director of the International Department Ministry of Health, Russia

OCR for page 199
  Ksenia Eroshina, M.P.H., Ph.D. Head of Monitoring & Evaluation Department Open Health Institute, Moscow, Russia   Alexey Mazus M.D. Head of Moscow AIDS Center   Inga Upmace, M.D. Deputy Director, AIDS Prevention Center, Latvia Steering Committee member of CEE-HRN (Central and Eastern Europe Harm Reduction Network)   Lily Hyde Harm Reduction and IEC Consultant International HIV/AIDS Alliance in Ukraine 6:30 p.m. Reception for all meeting participants at the ILO building, hosted by UNAIDS December 20, 2005 8:30–10:00 a.m. Lessons Learned: Experiences in the United States, Canada, Australia, and Western European Countries   Don C. Des Jarlais, Ph.D. Director of Research, Baron Edmond de Rothschild Chemical Institute, Beth Israel Medical Center Professor of Epidemiology, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York   Alex Wodak, FRACP, FChAM Director, Alcohol and Drug Service St. Vincent’s Hospital, Darlinghurst, Australia   Roel A. Coutinho, M.D., Ph.D. Director, Centre for Infectious Disease Control National Institute for Health and the Environment, The Netherlands

OCR for page 199
  Gerry V. Stimson Ph.D. Emeritus Professor, Imperial College London, and Executive Director, International Harm Reduction Association 10:00–10:15 a.m. Break 10:15–12:30 p.m. Illicit Drug Policies and the HIV Epidemic   Andrew Ball, M.B., B.S., FChAM Senior Strategy and Operations Advisor Department of HIV/AIDS World Health Organization   Christian Kroll Senior Coordinator, HIV/AIDS Unit Global Coordinator on HIV/AIDS UNODC   Chris Beyrer, M.D., M.P.H. Associate Professor, Department of Epidemiology Director, Johns Hopkins Fogarty AIDS International Training and Research Program Director, Johns Hopkins Center for Public Health & Human Rights Johns Hopkins Bloomberg School of Public Health   Tomas Hallberg Director, European Cities against Drugs (ECAD) Stockholm, Sweden   George Zazulin St. Petersburg Regional Director, ECAD, Russia   Alex Wodak, FRACP, FChAM Director, Alcohol and Drug Service St. Vincent’s Hospital, Darlinghurst, Australia   Raminta Stuikyte Director, Central and Eastern European Harm Reduction Network

OCR for page 199
12:30–1:30 p.m. Lunch 1:30–2:30 p.m. Community Perspectives   Mr. Loon Gangte (not able to attend; sent written remarks) President, Delhi Network of Positive People, India Regional Coordinator for South Asia Collaborative Fund for HIV Treatment Preparedness   Mr. Samuel Nugraha Partnership and Network Assistant UNAIDS Secretariat Indonesia 2:30–3:00 p.m. Methodological Considerations in Evaluating Evidence   Don C. Des Jarlais, Ph.D. Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center Professor of Epidemiology, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York 3:00–3:30 p.m. Public Comments 3:30 p.m. Adjourn